1. Home
  2. CRBP vs NRDY Comparison

CRBP vs NRDY Comparison

Compare CRBP & NRDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$7.63

Market Cap

134.8M

Sector

Health Care

ML Signal

HOLD

Logo Nerdy Inc.

NRDY

Nerdy Inc.

HOLD

Current Price

$0.89

Market Cap

127.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRBP
NRDY
Founded
2009
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
134.8M
127.9M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
CRBP
NRDY
Price
$7.63
$0.89
Analyst Decision
Strong Buy
Hold
Analyst Count
8
3
Target Price
$50.29
$1.25
AVG Volume (30 Days)
138.7K
564.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
64.31
7.32
EPS
N/A
N/A
Revenue
$4,822,272.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$220.00
$6.16
P/E Ratio
N/A
N/A
Revenue Growth
97.62
N/A
52 Week Low
$4.64
$0.77
52 Week High
$20.56
$1.90

Technical Indicators

Market Signals
Indicator
CRBP
NRDY
Relative Strength Index (RSI) 43.45 38.95
Support Level $6.73 $0.78
Resistance Level $8.43 $1.11
Average True Range (ATR) 0.47 0.05
MACD 0.00 -0.01
Stochastic Oscillator 38.50 5.64

Price Performance

Historical Comparison
CRBP
NRDY

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

About NRDY Nerdy Inc.

Nerdy Inc is a curated direct-to-consumer platform for live online learning. Its proprietary platform leverages technology, including artificial intelligence ("AI"), to connect students, users, parents, guardians, and purchasers of all ages to tutors, instructors, subject matter experts, educators, and other professionals. The company provides learning experiences across numerous subjects and multiple formats, including one-on-one instruction, small group tutoring, large format classes, tutor chat, essay review, adaptive assessments, and self-study tools. The company generates revenue by selling services to learners and institutions for one-on-one instruction and small group tutoring.

Share on Social Networks: